- Home
- MNDR vs CYCN Comparison
MNDR vs CYCN Comparison
Compare MNDR & CYCN Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Company Overview
Basic Information| Metric | MNDR | CYCN |
|---|---|---|
| Founded | 2016 | 2018 |
| Country | Singapore | United States |
| Employees | N/A | N/A |
| Industry | | Biotechnology: Pharmaceutical Preparations |
| Sector | | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 6.6M | 7.6M |
| IPO Year | 2024 | N/A |
Fundamental Metrics
Financial Performance| Metric | MNDR | CYCN |
|---|---|---|
| Price | $1.77 | $1.66 |
| Analyst Decision | | |
| Analyst Count | 0 | 0 |
| Target Price | N/A | N/A |
| AVG Volume (30 Days) | ★ 9.9M | 1.1M |
| Earning Date | 10-31-2025 | 11-12-2025 |
| Dividend Yield | N/A | N/A |
| EPS Growth | N/A | N/A |
| EPS | N/A | ★ N/A |
| Revenue | ★ $7,646,739.00 | $2,855,000.00 |
| Revenue This Year | $608,852.40 | N/A |
| Revenue Next Year | N/A | N/A |
| P/E Ratio | N/A | N/A |
| Revenue Growth | N/A | ★ 1371.65 |
| 52 Week Low | $1.53 | $1.28 |
| 52 Week High | $40.00 | $9.47 |
Technical Indicators
Market Signals| Indicator | MNDR | CYCN |
|---|---|---|
| Relative Strength Index (RSI) | 44.51 | 51.46 |
| Support Level | $1.85 | $1.48 |
| Resistance Level | $2.92 | $1.60 |
| Average True Range (ATR) | 0.55 | 0.09 |
| MACD | -0.05 | 0.05 |
| Stochastic Oscillator | 6.43 | 93.75 |
Price Performance
Historical ComparisonAbout MNDR Mobile-health Network Solutions Class A Ordinary Shares
Mobile-health Network Solutions is a company engaged in providing telehealth solutions in terms of various matrices, such as the number of patient consultations per day and the ranking of its mobile application. It provides services on its MaNaDr platform, which is accessible via mobile application and website. The MaNaDr platform is a platform designed and created by doctors, for doctors and users, equipped with services like consultations with doctors, e-commerce pharma store, and others. The company's operating segments are Telemedicine and other services, and the Sale of medicine and medical devices. The majority of the company's revenue is derived from the Telemedicine and other services segment. Geographically, it derives revenue from Singapore.
About CYCN Cyclerion Therapeutics Inc.
Cyclerion Therapeutics Inc is a clinical-stage biopharmaceutical company harnessing the power of soluble guanylate cyclase (sGC) pharmacology to discover, develop, and commercialize breakthrough treatments for serious and orphan diseases. Its focus is on enabling the full therapeutic potential of next-generation sGC stimulators. Its pipeline products include Olinciguat, Praliciguat, and others.